Pharming Group N.V.
PHARM.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | €12,758 | €7,079 | -€11,788 | €6,678 |
| Dep. & Amort. | €2,726 | €2,702 | €2,582 | €7,699 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €3,204 | €3,476 | €2,576 | €2,643 |
| Change in WC | €11,041 | -€1,390 | €1,419 | -€7,085 |
| Other Non-Cash | €2,297 | -€124 | €5,443 | -€604 |
| Operating Cash Flow | €32,026 | €11,743 | €232 | €9,331 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€70 | -€128 | -€288 | -€136 |
| Net Acquisitions | -€302 | -€18 | -€57,887 | €0 |
| Inv. Purchases | €0 | €0 | €0 | -€62,065 |
| Inv. Sales/Matur. | €23 | €17,101 | €67,866 | €52,411 |
| Other Inv. Act. | €0 | €0 | €0 | €0 |
| Investing Cash Flow | -€349 | €16,955 | €9,691 | -€9,790 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€1,096 | -€1,066 | -€715 | -€1,516 |
| Stock Issued | €0 | €0 | €0 | €0 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €11,029 | -€1,691 | -€6,004 | -€688 |
| Financing Cash Flow | €9,933 | -€2,757 | -€6,719 | -€2,204 |
| Forex Effect | -€1,330 | €6,057 | €1,945 | -€3,055 |
| Net Chg. in Cash | €40,279 | €31,998 | €5,149 | -€5,718 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €92,091 | €60,093 | €54,944 | €60,662 |
| End Cash | €132,370 | €92,091 | €60,093 | €54,944 |
| Free Cash Flow | €31,956 | €11,615 | -€56 | €9,195 |